BRD2 anticorps (Internal Region)

N° du produit ABIN544203

Détail du produit anti-BRD2 anticorps

Antigène: BRD2 (Bromodomain Containing 2 (BRD2))

Épitope: Internal Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BRD2 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Fonction: Rabbit polyclonal antibody raised against synthetic peptide of BRD2.

Réactivité croisée: Humain

Immunogène: A synthetic peptide (conjugated with KLH) corresponding to internal region of human BRD2.

Information d'application

Indications d'application: Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:50-100)
Western Blot (1:1000)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Références pour anticorps anti-BRD2 (ABIN544203)

Asangani, Dommeti, Wang, Malik, Cieslik, Yang, Escara-Wilke, Wilder-Romans, Dhanireddy, Engelke, Iyer, Jing, Wu, Cao, Qin, Wang, Feng, Chinnaiyan: "Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer." dans: Nature, Vol. 510, Issue 7504, pp. 278-82, (2014) (PubMed).

Pal, Evgrafov, Tabares, Zhang, Durner, Greenberg: "BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy." dans: American journal of human genetics, Vol. 73, Issue 2, pp. 261-70, (2003) (PubMed).

Crowley, Kaine, Yoshida, Nandi, Wolgemuth: "Reproductive cycle regulation of nuclear import, euchromatic localization, and association with components of Pol II mediator of a mammalian double-bromodomain protein." dans: Molecular endocrinology (Baltimore, Md.), Vol. 16, Issue 8, pp. 1727-37, (2002) (PubMed).

Denis, Vaziri, Guo, Faller: "RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F." dans: Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, Vol. 11, Issue 8, pp. 417-24, (2000) (PubMed).

Détails sur BRD2

Antigène: BRD2 (Bromodomain Containing 2 (BRD2))

Autre désignation: BRD2 (BRD2 Produits)

Synonymes: anticorps D6S113E, anticorps FSH, anticorps FSRG1, anticorps NAT, anticorps RING3, anticorps RNF3, anticorps AW228947, anticorps D17H6S113E, anticorps Frg-1, anticorps Fsrg-1, anticorps Fsrg1, anticorps Nat, anticorps Ring3, anticorps Rnf3, anticorps mKIAA4005, anticorps brd2-a, anticorps fsh, anticorps fsrg1, anticorps nat, anticorps ring3, anticorps rnf3, anticorps brd2, anticorps fe47f02, anticorps fi85h05, anticorps wu:fe47f02, anticorps wu:fi85h05, anticorps Ring3 protein, anticorps bromodomain containing 2, anticorps bromodomain containing 2 S homeolog, anticorps bromodomain containing 2a, anticorps CHLREDRAFT_190116, anticorps CHLREDRAFT_150233, anticorps CHLREDRAFT_182576, anticorps CHLREDRAFT_188250, anticorps BRD2, anticorps Brd2, anticorps brd2.S, anticorps brd2a

ID gène: 6046

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2